Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany".
Alexander Kuhlmann, J-Matthias Graf von der Schulenburg
Author Information
- Alexander Kuhlmann: Center for Health Economics Research Hannover (CHERH), Leibniz Universität Hannover, Otto-Brenner-Straße 1, 30159, Hanover, Germany. ak@ivbl.uni-hannover.de. ORCID
- J-Matthias Graf von der Schulenburg: Center for Health Economics Research Hannover (CHERH), Leibniz Universität Hannover, Otto-Brenner-Straße 1, 30159, Hanover, Germany.
No abstract text available.
- Pediatr Infect Dis J. 2002 Sep;21(9):810-5
[PMID: 12352800]
- BMC Infect Dis. 2017 Mar 14;17 (1):208
[PMID: 28292280]
- Eur J Health Econ. 2017 Apr;18(3):273-292
[PMID: 26905404]
- Eur J Health Econ. 2018 Apr;19(3):471-472
[PMID: 29411178]
- Vaccine. 2004 Oct 22;22(31-32):4203-14
[PMID: 15474710]
- Lancet. 2006 Mar 4;367(9512):740-8
[PMID: 16517274]
- BMJ. 2010 Jun 02;340:c2509
[PMID: 20519267]
- Value Health. 2010 Jan-Feb;13(1):8-13
[PMID: 19883405]
- Lancet. 2013 Jan 19;381(9862):214-22
[PMID: 23158882]
- Eur Respir J. 2015 Nov;46(5):1407-16
[PMID: 26160871]
- PLoS Med. 2014 Jun 03;11(6):e1001657
[PMID: 24892763]
- J Infect. 2012 Jul;65(1):17-24
[PMID: 22394683]
- Pediatr Infect Dis J. 2000 Mar;19(3):187-95
[PMID: 10749457]
Cost-Benefit Analysis
Germany
Humans
Infant
Pneumococcal Infections
Pneumococcal Vaccines
Vaccination
Vaccines, Conjugate
Pneumococcal Vaccines
Vaccines, Conjugate
